Clinical Trial Update: Study of the Effect of Fostamatinib Upon Cutaneous Inflammation in the Setting of Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of fostamatinib on skin inflammation in hidradenitis suppurativa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Fostamatinib (fostamatinib)

Snippet

Sponsor: Holdsworth House Medical Practice | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED